Who to call at Spektus Pharma, and when
Fundz watches for the moments Spektus Pharma starts buying, and tells you who to reach.
- An alert the day Spektus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spektus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spektus Pharma. With Fundz connected, it knows.
Spektus Pharma and GEBRO Holding Form Partnership for Global Commercialisation of ActraFlex®
Contract Type
partnership
CanadaBiotechnologyHealth CarePharmaceuticalDescription
Spektus Pharma Inc. and GEBRO Holding GmbH have entered a partnership to commercialize ActraFlex®, a medication designed for pain management. This collaboration will leverage both companies' expertise and aims to expand the product across Europe, the Americas, and selected international markets.
Quick answer
Spektus Pharma and GEBRO Holding Form Partnership for Global Commercialisation of ActraFlex® (November 13, 2026). Spektus Pharma is based in Canada.
- What agreement did Spektus Pharma announce on November 13, 2026?
- Spektus Pharma Inc. and GEBRO Holding GmbH have entered a partnership to commercialize ActraFlex®, a medication designed for pain management. This collaboration will leverage both companies' expertise and aims to expand the product across Europe, the Americas, and selected international markets.
- What does Spektus Pharma do?
- Spektus Pharma is a Canada-based pharmaceutical company focused on developing innovative pain management therapies.
- Where is Spektus Pharma based?
- Spektus Pharma is based in Canada.
- Which similar companies announced agreements around the same time?
- Sino Biopharmaceutical (November 13, 2026), Pfizer (November 14, 2026), Daiichi Sankyo Healthcare Co (November 10, 2026) and Essential Pharma (November 9, 2026) also announced agreements within 45 days of Spektus Pharma.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Daiichi Sankyo and iDEL Therapeutics Forge Global Research Partnership for Cancer Drug Development. (November 10, 2026)
- Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency. (November 9, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
Agreement Insights
What this usually meansSpektus Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.